A Phase IIb Study Comparing the Safety and Efficacy of Remimazolam and Midazolam in Colonoscopy Patients

Share
  • Twitter
  • Facebook
  • email
  • StumbleUpon
  • Delicious
  • Google Reader
  • LinkedIn
  • Google Bookmarks

    Plenary Session 1: Endoscopy/Colorectal Cancer Prevention
    Tuesday, October 21
    8:30 am – 10:00 am

    MODERATORS:    Mark B. Pochapin, MD, FACG
    David A. Johnson, MD, MACG

    Oral 19: A Phase IIb Study Comparing the Safety and Efficacy of Remimazolam and Midazolam in Colonoscopy Patients

    Daniel J. Pambianco, MD, FACG, Keith Borkett, BSc, Dennis Riff, MD, Peter Winkle, MD, Howard Schwartz, MD, Timothy Melson, MD, Karin Wilhelm-Ogunbiyi, MD, Charlottesville Medical Research, Charlottesville, VA, Paion UK Ltd., Cambridge, United Kingdom, Anaheim Clinical Trials, Anaheim, CA, Miami Research Institute, Miami, FL, Helen Keller Hospital, Sheffield, AL, PAION Deutschland GmbH, Anchen, Germany

    Read abstract

     

    Embargo Policy

    All research presented at the ACG Annual Scientific Meeting is strictly embargoed until 8:00 a.m. on the first day of the Annual Meeting. For 2014, this is Monday, October 20 at 8:00 a.m. EDT.

    Share
    • Twitter
    • Facebook
    • email
    • StumbleUpon
    • Delicious
    • Google Reader
    • LinkedIn
    • Google Bookmarks